• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
The Association between Exposures and Disease Characteristics in Familial Pulmonary Fibrosis.家族性肺纤维化中暴露与疾病特征的关系。
Ann Am Thorac Soc. 2022 Dec;19(12):2003-2012. doi: 10.1513/AnnalsATS.202203-267OC.
2
Serial changes of CT findings in patients with chronic hypersensitivity pneumonitis: imaging trajectories and predictors of fibrotic progression and acute exacerbation.慢性过敏性肺炎患者的 CT 表现的动态变化:纤维化进展和急性加重的影像学轨迹和预测因素。
Eur Radiol. 2021 Jun;31(6):3993-4003. doi: 10.1007/s00330-020-07469-2. Epub 2020 Nov 25.
3
Lung transplant in patients with familial pulmonary fibrosis.家族性肺纤维化患者的肺移植。
J Bras Pneumol. 2020;46(6):e20200032. doi: 10.36416/1806-3756/e20200032. Epub 2020 Jul 27.
4
Clinical, radiological and histopathological features of patients with familial pulmonary fibrosis.家族性肺纤维化患者的临床、放射学和组织病理学特征。
Respir Res. 2024 Jun 12;25(1):239. doi: 10.1186/s12931-024-02864-5.
5
Pathologic Criteria for the Diagnosis of Usual Interstitial Pneumonia vs Fibrotic Hypersensitivity Pneumonitis in Transbronchial Cryobiopsies.经支气管冷冻活检诊断普通间质性肺炎与纤维性过敏性肺炎的病理标准。
Mod Pathol. 2023 Sep;36(9):100221. doi: 10.1016/j.modpat.2023.100221. Epub 2023 May 24.
6
Integration and Application of Radiologic Patterns From Clinical Practice Guidelines on Idiopathic Pulmonary Fibrosis and Fibrotic Hypersensitivity Pneumonitis.特发性肺纤维化和纤维化性过敏性肺炎临床实践指南中放射学模式的整合与应用
Chest. 2023 Dec;164(6):1466-1475. doi: 10.1016/j.chest.2023.07.068. Epub 2023 Aug 2.
7
Validation of a computed tomography diagnostic model for differentiating fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis.验证用于区分纤维化性过敏性肺炎和特发性肺纤维化的计算机断层扫描诊断模型。
Respir Investig. 2024 Sep;62(5):798-803. doi: 10.1016/j.resinv.2024.07.002. Epub 2024 Jul 11.
8
Can CT distinguish hypersensitivity pneumonitis from idiopathic pulmonary fibrosis?计算机断层扫描(CT)能区分过敏性肺炎和特发性肺纤维化吗?
AJR Am J Roentgenol. 1995 Oct;165(4):807-11. doi: 10.2214/ajr.165.4.7676971.
9
Variable utility of mosaic attenuation to distinguish fibrotic hypersensitivity pneumonitis from idiopathic pulmonary fibrosis.马赛克衰减在鉴别纤维化型过敏性肺炎与特发性肺纤维化中的可变效用。
Eur Respir J. 2019 Jul 25;54(1). doi: 10.1183/13993003.00531-2019. Print 2019 Jul.
10
Impact of radiographic honeycombing on transplant free survival and efficacy of immunosuppression in fibrotic hypersensitivity pneumonitis.影像学表现蜂窝肺对特发性肺纤维化合并过敏性肺炎患者移植后无病生存率及免疫抑制疗效的影响。
BMC Pulm Med. 2023 Jun 22;23(1):224. doi: 10.1186/s12890-023-02523-3.

引用本文的文献

1
Scoping review of exposure questionnaires and surveys in interstitial lung disease.特发性肺纤维化(IPF)是一种慢性、进行性、纤维化性间质性肺疾病,具有高度的异质性和病死率。 2011 年美国胸科学会(ATS)和欧洲呼吸学会(ERS)联合发布的 IPF 临床诊断和治疗指南中,明确了 IPF 的诊断标准。 然而,由于 IPF 的临床表现多样,诊断较为困难,容易误诊和漏诊。 因此,对于 IPF 的高危人群,需要进行早期筛查和诊断,以提高 IPF 的早期诊断率和生存率。
BMJ Open Respir Res. 2024 May 15;11(1):e002155. doi: 10.1136/bmjresp-2023-002155.
2
Genetics and Genomics of Pulmonary Fibrosis: Charting the Molecular Landscape and Shaping Precision Medicine.肺纤维化的遗传学和基因组学:描绘分子图谱,塑造精准医学。
Am J Respir Crit Care Med. 2024 Aug 15;210(4):401-423. doi: 10.1164/rccm.202401-0238SO.
3
Tobacco smoking is associated with combined pulmonary fibrosis and emphysema and worse outcomes in interstitial lung disease.吸烟与肺纤维化合并肺气肿有关,并导致间质性肺疾病的预后更差。
Am J Physiol Lung Cell Mol Physiol. 2023 Aug 1;325(2):L233-L243. doi: 10.1152/ajplung.00083.2023. Epub 2023 Jun 27.
4
Genetics in Idiopathic Pulmonary Fibrosis: A Clinical Perspective.特发性肺纤维化中的遗传学:临床视角
Diagnostics (Basel). 2022 Nov 23;12(12):2928. doi: 10.3390/diagnostics12122928.
5
What Constitutes Family Ties? Exposures and Disease Phenotypes in Familial Pulmonary Fibrosis.什么构成了家族关系?家族性肺纤维化中的暴露因素和疾病表型。
Ann Am Thorac Soc. 2022 Dec;19(12):1971-1972. doi: 10.1513/AnnalsATS.202209-769ED.

本文引用的文献

1
Inhalational exposures in patients with fibrotic interstitial lung disease: Presentation, pulmonary function and survival in the Canadian Registry for Pulmonary Fibrosis.纤维化间质性肺疾病患者的吸入暴露:加拿大肺纤维化登记处的临床表现、肺功能和生存率。
Respirology. 2022 Aug;27(8):635-644. doi: 10.1111/resp.14267. Epub 2022 May 5.
2
The detrimental effect of quantity of smoking on survival in progressive fibrosing ILD.吸烟量对进行性纤维化间质性肺病患者生存的有害影响。
Respir Med. 2022 Apr;194:106760. doi: 10.1016/j.rmed.2022.106760. Epub 2022 Feb 5.
3
Gender and racial equity in clinical research for idiopathic pulmonary fibrosis: a systematic review and meta-analysis.特发性肺纤维化临床研究中的性别和种族公平性:一项系统评价和荟萃分析。
Eur Respir J. 2022 Mar 3;59(3). doi: 10.1183/13993003.02969-2021. Print 2022 Mar.
4
Tobacco Smoking and Risk for Pulmonary Fibrosis: A Prospective Cohort Study From the UK Biobank.吸烟与肺纤维化风险:来自英国生物银行的一项前瞻性队列研究。
Chest. 2021 Sep;160(3):983-993. doi: 10.1016/j.chest.2021.04.035. Epub 2021 Apr 24.
5
A comprehensive assessment of environmental exposures and the medical history guides multidisciplinary discussion in interstitial lung disease.全面评估环境暴露和病史可指导间质性肺疾病的多学科讨论。
Respir Med. 2021 Apr;179:106333. doi: 10.1016/j.rmed.2021.106333. Epub 2021 Feb 11.
6
Characteristics and Prevalence of Domestic and Occupational Inhalational Exposures Across Interstitial Lung Diseases.特发性肺纤维化及其他间质性肺疾病患者家庭和职业性吸入暴露的特征和流行率。
Chest. 2021 Jul;160(1):209-218. doi: 10.1016/j.chest.2021.02.026. Epub 2021 Feb 20.
7
Identification and Remediation of Environmental Exposures in Patients With Interstitial Lung Disease: Evidence Review and Practical Considerations.环境暴露物在间质性肺疾病患者中的识别和处理:证据回顾和实际考虑。
Chest. 2021 Jul;160(1):219-230. doi: 10.1016/j.chest.2021.02.021. Epub 2021 Feb 18.
8
Lifestyle and Clinical Risk Factors for Incident Rheumatoid Arthritis-associated Interstitial Lung Disease.生活方式和临床危险因素与类风湿关节炎相关的间质性肺疾病发病有关。
J Rheumatol. 2021 May;48(5):656-663. doi: 10.3899/jrheum.200863. Epub 2020 Nov 15.
9
Diagnosis of Hypersensitivity Pneumonitis in Adults. An Official ATS/JRS/ALAT Clinical Practice Guideline.成人过敏性肺炎的诊断。美国胸科学会/日本呼吸学会/拉丁美洲胸科学会临床实践指南。
Am J Respir Crit Care Med. 2020 Aug 1;202(3):e36-e69. doi: 10.1164/rccm.202005-2032ST.
10
Occupational and environmental risk factors for idiopathic pulmonary fibrosis in Australia: case-control study.澳大利亚特发性肺纤维化的职业和环境风险因素:病例对照研究。
Thorax. 2020 Oct;75(10):864-869. doi: 10.1136/thoraxjnl-2019-214478. Epub 2020 Jul 13.

家族性肺纤维化中暴露与疾病特征的关系。

The Association between Exposures and Disease Characteristics in Familial Pulmonary Fibrosis.

机构信息

Department of Medicine.

Department of Radiology, Ohio State University Wexner Medical Center, Columbus, Ohio.

出版信息

Ann Am Thorac Soc. 2022 Dec;19(12):2003-2012. doi: 10.1513/AnnalsATS.202203-267OC.

DOI:10.1513/AnnalsATS.202203-267OC
PMID:35877079
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9743479/
Abstract

Heterogeneous characteristics are observed in familial pulmonary fibrosis (FPF), suggesting that nongenetic factors contribute to disease manifestations. To determine the relationship between environmental exposures and disease characteristics of FPF, including the morphological characteristics on chest computed tomography (CT) scan, and timing of FPF symptom onset, lung transplantation, or death. Subjects with FPF with an exposure questionnaire and chest CT were selected from a prospective cohort at Vanderbilt. Disease characteristics were defined by lung parenchymal findings on chest CT associated with fibrotic hypersensitivity pneumonitis (fHP) or usual interstitial pneumonia (UIP) and by time from birth to symptom onset or a composite of lung transplantation or death. After assessing the potential for confounding by sex or smoking, adjusted logistic or Cox proportional hazards regression models identified exposures associated with fHP or UIP CT findings. Findings were validated in a cohort of patients with sporadic pulmonary fibrosis enrolled in the LTRC (Lung Tissue Research Consortium) study. Among 159 subjects with FPF, 98 (61.6%) were males and 96 (60.4%) were ever-smokers. Males were less likely to have CT features of fHP, including mosaic attenuation (FPF: adjusted [for sex and smoking] odds ratio [aOR], 0.27; 95% confidence interval [CI], 0.09-0.76;  = 0.01; LTRC: aOR, 0.35; 95% CI, 0.21-0.61;  = 0.0002). Organic exposures, however, were not consistently associated with fHP features in either cohort. Smoking was a risk factor for honeycombing in both cohorts (FPF: aOR, 2.19; 95% CI, 1.12-4.28;  = 0.02; LTRC: aOR, 1.69; 95% CI, 1.22-2.33;  = 0.002). Rock dust exposure may also be associated with honeycombing, although the association was not statistically-significant when accounting for sex and smoking (FPF: aOR, 2.27; 95% CI, 0.997-5.15;  = 0.051; LTRC: aOR, 1.51; 95% CI, 0.97-2.33;  = 0.07). In the FPF cohort, ever-smokers experienced a shorter transplant-free survival (adjusted hazard ratio, 1.64; 95% CI, 1.07-2.52;  = 0.02), whereas sex was not associated with differential survival (male adjusted hazard ratio, 0.75; 95% CI, 0.50-1.14;  = 0.18). In FPF, smoking contributes to shortened transplant-free survival and development of honeycombing, a finding that is also likely applicable to sporadic pulmonary fibrosis. Females are more likely to manifest CT features of fHP (mosaic attenuation), a finding that was incompletely explained by sex differences in exposures. These findings may have implications for pulmonary fibrosis classification and management.

摘要

家族性肺纤维化(FPF)存在异质性特征,提示非遗传因素也与疾病表现有关。为了确定环境暴露与 FPF 的疾病特征之间的关系,包括胸部计算机断层扫描(CT)上的形态特征,以及 FPF 症状发作、肺移植或死亡的时间。在范德比尔特前瞻性队列中,从患有 FPF 的患者中选择了具有暴露问卷和胸部 CT 的患者。疾病特征通过与纤维性过敏性肺炎(fHP)或普通间质性肺炎(UIP)相关的肺实质发现,以及从出生到症状发作或肺移植或死亡的复合时间来定义。在评估了性别或吸烟的混杂因素后,调整后的逻辑或 Cox 比例风险回归模型确定了与 fHP 或 UIP CT 发现相关的暴露因素。在 LTRC(肺组织研究联合会)研究中招募的散发性肺纤维化患者队列中验证了这些发现。在 159 名 FPF 患者中,98 名(61.6%)为男性,96 名(60.4%)为曾吸烟者。男性更不可能具有 fHP 的 CT 特征,包括马赛克衰减(FPF:调整后[性别和吸烟]比值比[aOR],0.27;95%置信区间[CI],0.09-0.76;=0.01;LTRC:aOR,0.35;95%CI,0.21-0.61;=0.0002)。然而,在两个队列中,有机暴露与 fHP 特征均无一致相关性。吸烟是两个队列中出现蜂窝肺的危险因素(FPF:aOR,2.19;95%CI,1.12-4.28;=0.02;LTRC:aOR,1.69;95%CI,1.22-2.33;=0.002)。尽管在考虑性别和吸烟因素时,该关联并不具有统计学意义(FPF:aOR,2.27;95%CI,0.997-5.15;=0.051;LTRC:aOR,1.51;95%CI,0.97-2.33;=0.07),但可能与尘肺病暴露有关。在 FPF 队列中,曾吸烟者经历了更短的无移植生存(调整后的危险比,1.64;95%CI,1.07-2.52;=0.02),而性别与生存差异无关(男性调整后的危险比,0.75;95%CI,0.50-1.14;=0.18)。在 FPF 中,吸烟会导致无移植生存时间缩短和蜂窝肺的发展,这一发现也可能适用于散发性肺纤维化。女性更可能表现出 fHP(马赛克衰减)的 CT 特征,这一发现不能完全用性别差异来解释。这些发现可能对肺纤维化分类和管理具有重要意义。